CIK 0001034842 · Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943248524
- Phone
- 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-02 | Schorno Dean L EVP & Chief Financial Officer | Option exercise | +694 | $12.70 | $9K | 79,056 |
| 2026-09-02 | Schorno Dean L EVP & Chief Financial Officer | Option exercise | +620 | $18.70 | $12K | 79,676 |
| 2026-09-02 | Schorno Dean L EVP & Chief Financial Officer | Option exercise | +2,000 | $24.20 | $48K | 81,676 |
| 2026-09-02 | Schorno Dean L EVP & Chief Financial Officer | Option exercise | +1,286 | $24.20 | $31K | 82,962 |
| 2026-09-02 | Schorno Dean L EVP & Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −694 | 12,824 | ||
| 2026-09-02 | Schorno Dean L EVP & Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −620 | 9,012 | ||
| 2026-09-02 | Schorno Dean L EVP & Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −2,000 | 7,999 | ||
| 2026-09-02 | Schorno Dean L EVP & Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −1,286 | 15,867 | ||
| 2026-09-01 | Schorno Dean L EVP & Chief Financial Officer | Shares withheld for taxes | −928 | $47.50 | $44K | 78,362 |
| 2026-09-01 | Santos David A EVP, Chief Commercial Officer | Shares withheld for taxes | −874 | $47.50 | $42K | 61,622 |
| 2026-09-01 | RODRIGUEZ RAUL R CEO, President | Shares withheld for taxes | −2,424 | $47.50 | $115K | 273,362 |
| 2026-09-01 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Shares withheld for taxes | −877 | $47.50 | $42K | 50,559 |
| 2026-07-08 | HANNAH ALISON L. EVP, Chief Medical Officer | Grant or award | +24,400 | 35,025 | ||
| 2026-06-22 | Ali-Jackson Kamil Director | Sale 10b5-1 | −2,500 | $35.00 | $88K | 10,125 |
| 2026-06-17 | Rojkjaer Lisa EVP, Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +9,375 | 9,375 | ||
| 2026-06-17 | Rojkjaer Lisa EVP, Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +7,394 | 7,394 | ||
| 2026-06-17 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Grant or award · Employee Stock Option (right to buy) | +7,394 | 7,394 | ||
| 2026-06-17 | RODRIGUEZ RAUL R CEO, President | Grant or award · Employee Stock Option (right to buy) | +31,700 | 31,700 | ||
| 2026-06-17 | Santos David A EVP, Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +7,394 | 7,394 | ||
| 2026-06-17 | Schorno Dean L EVP & Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +7,394 | 7,394 |
Page 1 of 9 · 176 trades